Logo image of CMLS

CUMULUS MEDIA INC-CL A (CMLS) Stock Fundamental Analysis

NASDAQ:CMLS - Nasdaq - US2310828015 - Common Stock - Currency: USD

0.189  -0.04 (-18.95%)

After market: 0.16 -0.03 (-15.34%)

Fundamental Rating

2

Taking everything into account, CMLS scores 2 out of 10 in our fundamental rating. CMLS was compared to 96 industry peers in the Media industry. CMLS may be in some trouble as it scores bad on both profitability and health. CMLS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CMLS had negative earnings in the past year.
CMLS had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CMLS reported negative net income in multiple years.
CMLS had a positive operating cash flow in 4 of the past 5 years.
CMLS Yearly Net Income VS EBIT VS OCF VS FCFCMLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

The Return On Assets of CMLS (-25.32%) is worse than 78.35% of its industry peers.
With a Return On Equity value of -4075.01%, CMLS is not doing good in the industry: 81.44% of the companies in the same industry are doing better.
CMLS has a worse Return On Invested Capital (0.01%) than 63.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMLS is below the industry average of 6.73%.
Industry RankSector Rank
ROA -25.32%
ROE -4075.01%
ROIC 0.01%
ROA(3y)-10.83%
ROA(5y)-6.94%
ROE(3y)-1370.73%
ROE(5y)-824.61%
ROIC(3y)2.36%
ROIC(5y)2.14%
CMLS Yearly ROA, ROE, ROICCMLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

With a Operating Margin value of 0.01%, CMLS is not doing good in the industry: 63.92% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of CMLS has declined.
With a decent Gross Margin value of 60.80%, CMLS is doing good in the industry, outperforming 74.23% of the companies in the same industry.
CMLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.01%
PM (TTM) N/A
GM 60.8%
OM growth 3Y-89.25%
OM growth 5Y-76.27%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y-0.89%
CMLS Yearly Profit, Operating, Gross MarginsCMLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CMLS is destroying value.
Compared to 1 year ago, CMLS has more shares outstanding
The number of shares outstanding for CMLS has been reduced compared to 5 years ago.
Compared to 1 year ago, CMLS has a worse debt to assets ratio.
CMLS Yearly Shares OutstandingCMLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CMLS Yearly Total Debt VS Total AssetsCMLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.48, we must say that CMLS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.48, CMLS is not doing good in the industry: 63.92% of the companies in the same industry are doing better.
A Debt/Equity ratio of 96.41 is on the high side and indicates that CMLS has dependencies on debt financing.
CMLS's Debt to Equity ratio of 96.41 is on the low side compared to the rest of the industry. CMLS is outperformed by 81.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 96.41
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACC0
WACC8.05%
CMLS Yearly LT Debt VS Equity VS FCFCMLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 1.85 indicates that CMLS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.85, CMLS is doing good in the industry, outperforming 63.92% of the companies in the same industry.
CMLS has a Quick Ratio of 1.85. This is a normal value and indicates that CMLS is financially healthy and should not expect problems in meeting its short term obligations.
CMLS has a better Quick ratio (1.85) than 63.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
CMLS Yearly Current Assets VS Current LiabilitesCMLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

2

3. Growth

3.1 Past

CMLS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -65.57%.
The Revenue has decreased by -2.07% in the past year.
The Revenue has been decreasing by -5.77% on average over the past years.
EPS 1Y (TTM)-65.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.18%
Revenue 1Y (TTM)-2.07%
Revenue growth 3Y-3.36%
Revenue growth 5Y-5.77%
Sales Q2Q%-6.35%

3.2 Future

Based on estimates for the next years, CMLS will show a small growth in Earnings Per Share. The EPS will grow by 7.18% on average per year.
CMLS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.60% yearly.
EPS Next Y3.11%
EPS Next 2Y15.1%
EPS Next 3Y7.18%
EPS Next 5YN/A
Revenue Next Year-8.62%
Revenue Next 2Y-2.1%
Revenue Next 3Y-1.18%
Revenue Next 5Y0.6%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMLS Yearly Revenue VS EstimatesCMLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CMLS Yearly EPS VS EstimatesCMLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10 20 30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CMLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CMLS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CMLS Price Earnings VS Forward Price EarningsCMLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMLS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.3
CMLS Per share dataCMLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.1%
EPS Next 3Y7.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CMLS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CUMULUS MEDIA INC-CL A

NASDAQ:CMLS (5/1/2025, 8:53:06 PM)

After market: 0.16 -0.03 (-15.34%)

0.189

-0.04 (-18.95%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners40.09%
Inst Owner Change-3.09%
Ins Owners10.97%
Ins Owner Change0%
Market Cap3.30M
Analysts45.71
Price Target11.22 (5836.51%)
Short Float %0.88%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.38%
Min EPS beat(2)-10.75%
Max EPS beat(2)33.5%
EPS beat(4)2
Avg EPS beat(4)-42.91%
Min EPS beat(4)-231.51%
Max EPS beat(4)37.11%
EPS beat(8)4
Avg EPS beat(8)-21.47%
EPS beat(12)5
Avg EPS beat(12)-17.82%
EPS beat(16)8
Avg EPS beat(16)-20.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-2.28%
Max Revenue beat(2)-2.06%
Revenue beat(4)0
Avg Revenue beat(4)-2.23%
Min Revenue beat(4)-2.51%
Max Revenue beat(4)-2.06%
Revenue beat(8)0
Avg Revenue beat(8)-1.8%
Revenue beat(12)2
Avg Revenue beat(12)-0.91%
Revenue beat(16)3
Avg Revenue beat(16)-0.79%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-3.2%
EPS NQ rev (3m)-10.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.31%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-4.57%
Revenue NY rev (1m)-5.3%
Revenue NY rev (3m)-7.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB N/A
EV/EBITDA 10.3
EPS(TTM)-4.52
EYN/A
EPS(NY)-2.36
Fwd EYN/A
FCF(TTM)-1.29
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS47.42
BVpS0.4
TBVpS-33.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.32%
ROE -4075.01%
ROCE 0.01%
ROIC 0.01%
ROICexc 0.01%
ROICexgc 0.02%
OM 0.01%
PM (TTM) N/A
GM 60.8%
FCFM N/A
ROA(3y)-10.83%
ROA(5y)-6.94%
ROE(3y)-1370.73%
ROE(5y)-824.61%
ROIC(3y)2.36%
ROIC(5y)2.14%
ROICexc(3y)2.54%
ROICexc(5y)2.34%
ROICexgc(3y)8%
ROICexgc(5y)7.4%
ROCE(3y)2.99%
ROCE(5y)2.71%
ROICexcg growth 3Y-88.54%
ROICexcg growth 5Y-74.64%
ROICexc growth 3Y-88.06%
ROICexc growth 5Y-75.01%
OM growth 3Y-89.25%
OM growth 5Y-76.27%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y-0.89%
F-Score3
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 96.41
Debt/FCF N/A
Debt/EBITDA 11.32
Cap/Depr 32.92%
Cap/Sales 2.35%
Interest Coverage 0
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z 0.48
F-Score3
WACC8.05%
ROIC/WACC0
Cap/Depr(3y)43.63%
Cap/Depr(5y)45.37%
Cap/Sales(3y)2.85%
Cap/Sales(5y)2.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.18%
EPS Next Y3.11%
EPS Next 2Y15.1%
EPS Next 3Y7.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.07%
Revenue growth 3Y-3.36%
Revenue growth 5Y-5.77%
Sales Q2Q%-6.35%
Revenue Next Year-8.62%
Revenue Next 2Y-2.1%
Revenue Next 3Y-1.18%
Revenue Next 5Y0.6%
EBIT growth 1Y-99.71%
EBIT growth 3Y-89.62%
EBIT growth 5Y-77.64%
EBIT Next Year1480.77%
EBIT Next 3Y147.42%
EBIT Next 5Y86.44%
FCF growth 1Y-429.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-109.85%
OCF growth 3YN/A
OCF growth 5YN/A